The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway
Open accessAbstract
Several genetic forms of human dwarfism have been linked to activating mutations in FGF receptor 3, indicating that FGF signaling has a critical role in chondrocyte maturation and skeletal development. However, the mechanisms through which FGFs affect chondrocyte proliferation and differentiation remain poorly understood. We show here that activation of FGF signaling inhibits chondrocyte proliferation both in a rat chondrosarcoma (RCS) cell line and in primary murine chondrocytes. FGF treatment of RCS cells induces phosphorylation of STAT-1, its translocation to the nucleus, and an increase in the expression of the cell-cycle inhibitor p21WAF1/CIP1. We have used primary chondrocytes from STAT-1 knock-out mice to provide genetic evidence that STAT-1 function is required for the FGF mediated growth inhibition. Furthermore, FGF treatment of metatarsal rudiments from wild-type and STAT-1(-/-) murine embryos produces a drastic impairment of chondrocyte proliferation and bone development in wild-type, but not in STAT-1(-/-) rudiments. We propose that STAT-1 mediated down regulation of chondrocyte proliferation by FGF signaling is an homeostatic mechanism which ensures harmonious bone development and morphogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Receptor Specificity of the Fibroblast Growth Factor Family
Ornitz, D. M., Xu, J., Colvin, J. S., McEwen, D. G., MacArthur, C. A., Coulier, F., Gao, G., & Goldfarb, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15292 · Cited by 1,871
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Self-citationThe Fgf Family of Growth Factors and Oncogenes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60305-x · Cited by 1,145
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., & Leder, P. (1996) · Cell · doi:10.1016/s0092-8674(00)81069-7 · Cited by 1,070
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G., & Ornitz, D. M. (1996) · Nature Genetics · doi:10.1038/ng0496-390 · Cited by 873
Chin, Y. E., Kitagawa, M., Su, W.-C. S., You, Z.-H., Iwamoto, Y., & Fu, X.-Y. (1996) · Science · doi:10.1126/science.272.5262.719 · Cited by 696
Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2
Saxton, T. M., Henkemeyer, M., Gasca, S., Shen, R., Rossi, D. J., Shalaby, F., Feng, G.-S., & Pawson, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2352 · Cited by 480
Naski, M. C., Colvin, J. S., Coffin, J. D., & Ornitz, D. M. (1998) · Development · doi:10.1242/dev.125.24.4977 · Cited by 420
Ras-Independent Growth Factor Signaling by Transcription Factor Tyrosine Phosphorylation
Silvennoinen, O., Schindler, C., Schlessinger, J., & Levy, D. E. (1993) · Science · doi:10.1126/science.8378775 · Cited by 338
Self-citationFGFR activation in skeletal disorders: Too much of a good thing
Webster, M. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01131-1 · Cited by 317
Su, W.-C. S., Kitagawa, M., Xue, N., Xie, B., Garofalo, S., Cho, J., Deng, C., Horton, W. A., & Fu, X.-Y. (1997) · Nature · doi:10.1038/386288a0 · Cited by 304
Amling, M., Neff, L., Tanaka, S., Inoue, D., Kuida, K., Weir, E., Philbrick, W. M., Broadus, A. E., & Baron, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.1.205 · Cited by 304
Coffin, J. D., Florkiewicz, R. Z., Neumann, J., Mort-Hopkins, T., Dorn, G. W., Lightfoot, P., German, R., Howles, P. N., Kier, A., & O'Toole, B. A. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.12.1861 · Cited by 301
Li, C. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.35 · Cited by 219
FGF signaling in skeletal development
Ornitz, D. M. (1998) · Frontiers in Bioscience · doi:10.2741/a321 · Cited by 215
Functions of fibroblast growth factors in vertebrate development
Goldfarb, M. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00039-1 · Cited by 214
Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation.
Kato, Y., & Iwamoto, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39448-7 · Cited by 193
Fibroblast growth factor receptors: lessons from the genes
Burke, D. F., Wilkes, D. C., Blundell, T. L., & Malcolm, S. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01170-5 · Cited by 170
Abdollahi, A., Lord, K. A., Hoffman‐Liebermann, B., & Liebermann, D. A. (1991) · PubMed · Cited by 151
Mukhopadhyay, K., Lefebvre, V., Zhou, G. D., Garofalo, S., Kimura, J. H., & Crombrugghe, B. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27711 · Cited by 146
Legeai‐Mallet, L., Benoist-Lasselin, C., Delezoide, A., Münnich, A., & Bonaventure, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13007 · Cited by 141
Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation
Wroblewski, J., & Edwall-Arvidsson, C. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100510 · Cited by 98
Effects of Fibroblast Growth Factor-2 on Longitudinal Bone Growth
Mancilla, E. E., Luca, F. D., Uyeda, J. A., Czerwiec, F. S., & Baron, J. (1998) · Endocrinology · doi:10.1210/endo.139.6.6032 · Cited by 87
Activation of FGF receptors by mutations in the transmembrane domain
Li, Y., Mangasarian, K., Mansukhani, A., & Basilico, C. (1997) · Oncogene · doi:10.1038/sj.onc.1200983 · Cited by 80
Self-citationShah, K., Astley, R., & Cameron, A. H. (1973) · Journal of Medical Genetics · doi:10.1136/jmg.10.3.243 · Cited by 27
Cited by
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Developmental regulation of the growth plate
Kronenberg, H. M. (2003) · Nature · doi:10.1038/nature01657 · Cited by 2,849
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Reaching a Genetic and Molecular Understanding of Skeletal Development
Karsenty, G., & Wagner, E. F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00157-0 · Cited by 1,601
Metadata
- Authors
- Sahni, M., Ambrosetti, D.-C., Mansukhani, A., Gertner, R., Levy, D., & Basilico, C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-06-01
- Volume
- 13
- Issue
- 11
- Pages
- 1361-1366
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2115675418
- Cited by
- 375
- References
- 26
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.